Tuesday, May 11, 2021
Home Lead Story New Antibody Approach to Tackle Ebola, Research To Make Successful Treatments For...

New Antibody Approach to Tackle Ebola, Research To Make Successful Treatments For The Deadly Viral Infection

Antibodies intended for treatment are normally collected from the blood of people who have survived infection. But they can also be tricky to obtain and carry heightened risks such as potential persistent viruses or other pathogens.

Scientists working on developing vaccines against Ebola have found they can “harvest” antibodies from volunteers vaccinated in research trials and use them to make treatments for the deadly viral infection.

In a study published Tuesday in the journal Cell Reports, the scientists said the approach could be used for Ebola and other newly emerging deadly diseases caused by viruses.

The technique, based on people exposed to the Ebola vaccine but not the Ebola virus itself, suggests protective therapies could be developed from people who are disease-free.

“It is a small, extra step that could lead to new antibody therapies from an increased pool of donors and with reduced risk,” said Alain Townsend, a professor at the MRC Human Immunology Unit at Britain’s Oxford University.

FILE - Health workers treat an unconfirmed Ebola patient inside an Ebola Treatment Center (ETC) in Butembo, Democratic Republic of the Congo, Nov. 3, 2018.
Health workers treat an unconfirmed Ebola patient inside an Ebola Treatment Center (ETC) in Butembo, Democratic Republic of the Congo, Nov. 3, 2018.

He noted that besides Ebola, many experimental vaccines for other life-threatening infections, such as H5N1 and H7N9 bird flu and Middle East Respiratory Syndrome (MERS), are entering clinical trials and could offer similar opportunities for antibodies to be collected.

Ebola is now spreading in Democratic Republic of Congo, where World Health Organization data show at least 676 people have been killed and more than 700 others infected in an outbreak that started eight months ago.

The largest Ebola epidemic in history swept through Sierra Leone, Liberia and Guinea in 2013-2016, killing more than 11,000 people. That outbreak prompted a global push to develop vaccines and treatments — and some, including a protective shot developed by Merck and several antibody therapies for infected patients, have been deployed in the Congo outbreak.

vaccine
The technique, based on people exposed to the Ebola vaccine but not the Ebola virus itself, suggests protective therapies could be developed from people who are disease-free. Pixbay

Antibodies intended for treatment are normally collected from the blood of people who have survived infection. But they can also be tricky to obtain and carry heightened risks such as potential persistent viruses or other pathogens.

The Oxford team decided to try using blood from trial volunteers who had been given an experimental Ebola vaccine and whose immune system had responded to the shot by making antibodies. They successfully isolated 82 antibodies taken from 11 volunteers in trial at Oxford’s Jenner Institute.

Also Read: NASA Wants Humans To Reach Mars By 2033

They found that despite having less time to develop, a third of the antibodies were effective at neutralizing a strain of Ebola known as Zaire — the one causing the Congo outbreak.

The scientists then made a cocktail of four of the antibodies to create a treatment, which successfully cured six guinea pigs of Ebola when it was administered three days after infection. (VOA)

STAY CONNECTED

19,511FansLike
362FollowersFollow
1,773FollowersFollow

Most Popular

Save Time & Money With Asset Management Software

Asset management is one of the core responsibilities for owners and managers. When it comes to IT-related asset management (ITAM), there are many approaches...

Himachal Locals Stand Guard Against The Pandemic

With Himachal Pradesh Chief Minister Jai Ram Thakur continuing to motivate the panchayat heads to play a crucial role to trace and quarantine all...

Study Shows Obesity Increases Risk Of Covid Infection

People with increasing body mass index (BMI) may be at the risk of testing positive for SARS-CoV-2, the virus which causes Covid-19 finds a...

Common Myths About Adult Immunisation Busted

While vaccinations remain the most effective prevention strategy to maintain immunity for a prolonged period, adult immunization remains neglected. Adult immunization myths prevail as...

UN Experts: Islamic State Committed Genocide Against Yazidis

Karim Khan, head of a UN team investigating the Islamic State (IS) crimes in Iraq, said that there is "clear and convincing evidence" that...

Is Taiwan’s Silicon Shield Enough To Protect It From Chinese Aggression?

The global shortage of semiconductors, or microchips — the “brains” in all electronic devices, has heightened the geopolitical significance of Taiwan and its chip-making...

Samsung Develops CXL-Based DRAM Memory Tech For Data Centres

Samsung Electronics said on Tuesday it has developed a new DRAM memory technology based on the Compute Express Link (CXL) interconnect standard that can...

The Right Way to Wield Influence: Influencer Masoom Minawala Mehta

"Presence on social media also commands a certain responsibility", says fashion influencer Masoom Minawala Mehta There is such a cloud around the term "influencers"; in...

Recent Comments